These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8380004)

  • 1. Arginine-79 in the first epidermal growth factor domain of factor VII is essential for the interaction with tissue factor.
    Sridhara S; Clarke BJ; Blajchman MA
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):505-8. PubMed ID: 8380004
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304-->Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor.
    Matsushita T; Kojima T; Emi N; Takahashi I; Saito H
    J Biol Chem; 1994 Mar; 269(10):7355-63. PubMed ID: 8125953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that an Arg79-->Gln substitution in human factor VII is not associated with a reduction in coagulant activity.
    Kazama Y; Foster DC; Kisiel W
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):697-702. PubMed ID: 1489892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor.
    Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ
    Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain.
    Kavlie A; Orning L; Grindflek A; Stormorken H; Prydz H
    Thromb Haemost; 1998 Jun; 79(6):1136-43. PubMed ID: 9657438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of rabbit and human recombinant tissue factor reagents.
    Denson KW; Reed SV; Haddon ME; Woodhams B; Brucato C; Ruiz J
    Thromb Res; 1999 May; 94(4):255-61. PubMed ID: 10336242
    [No Abstract]   [Full Text] [Related]  

  • 7. The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and X.
    Bjorklid E; Storm E; Osterud B; Prydz H
    Scand J Haematol; 1975 Mar; 14(1):65-70. PubMed ID: 1121648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function.
    Kemball-Cook G; Johnson DJ; Takamiya O; Banner DW; McVey JH; Tuddenham EG
    J Biol Chem; 1998 Apr; 273(14):8516-21. PubMed ID: 9525966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X].
    Zubairov DM; Baĭkeev RF; Byshevskiĭ ASh; Tersenov OA
    Biokhimiia; 1984 Jun; 49(6):971-5. PubMed ID: 6466743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor.
    Wildgoose P; Kazim AL; Kisiel W
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7290-4. PubMed ID: 2402509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological control of factor VII.
    Nemerson Y
    Thromb Haemost; 1976 Feb; 35(1):96-100. PubMed ID: 989197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of different glycosylation patterns on factor VII biological activity.
    Sutkeviciute I; Mistiniene E; Sereikaite J; Bumelis VA
    Biochimie; 2009 Sep; 91(9):1123-30. PubMed ID: 19524011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor.
    Silverberg SA; Nemerson Y; Zur M
    J Biol Chem; 1977 Dec; 252(23):8481-8. PubMed ID: 925006
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VII and haemostasis: interaction between abnormal factors VII and tissue thromboplastins.
    Girolami A; Simioni P; Steffan A
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):749-50. PubMed ID: 2133255
    [No Abstract]   [Full Text] [Related]  

  • 18. Consumption of serum factors and prothrombin during intravascular clotting in rabbits.
    Rapaport SI; Hjort PF; Patch MJ; Jeremic M
    Scand J Haematol; 1966; 3(1):59-75. PubMed ID: 5914457
    [No Abstract]   [Full Text] [Related]  

  • 19. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F; Kelly CR; Ruf W; Edgington TS
    Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor.
    Clarke BJ; Ofosu FA; Sridhara S; Bona RD; Rickles FR; Blajchman MA
    FEBS Lett; 1992 Feb; 298(2-3):206-10. PubMed ID: 1371973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.